U.S. Vaccine Program Now Flush With Cash, but Short on Key Details

A $5 billion federal program aims to make better Covid vaccines. But vaccine makers are confused by murky regulatory guidance.

Author: Benjamin Mueller Noah Weiland and Carl Zimmer